BSC
WST icon

BOLTON SECURITIES CORPORATION’s West Pharmaceutical WST Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Buy
+5,245
New +$1.31M 0.06% 321
2025
Q3 		$357K Buy
+1,359
New +$330K 0.02% 599
2025
Q1 		$447K Buy
+1,997
New +$550K 0.03% 510

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's WST Position: Q1 2026 in Review

BOLTON SECURITIES CORPORATION opened a new position in West Pharmaceutical (WST) in Q1 2026: 5,245 shares worth $1.31M. The stake represents 0.06% of the portfolio and ranks #321 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in WST as recently as Q3 2025.

BOLTON SECURITIES CORPORATION first reported a position in WST in Q1 2025 and has held it in 3 quarters since. 760 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • BOLTON SECURITIES CORPORATION held 5,245 shares of West Pharmaceutical worth $1.31M as of Q1 2026.
  • West Pharmaceutical was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
  • West Pharmaceutical made up 0.06% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #321 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in West Pharmaceutical in Q1 2025 and has held it in 3 quarters since.
  • 760 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.